Sanofi replaces chief Paul Hudson with Merck executive

French drugmaker says incoming boss Belén Garijo will bring ‘increased rigour’

giovedì 12 febbraio 2026 New tab

Other newsrooms on this story

· 2 sources

Boardroom shake-up at European drugmaker grants Lars Rebien Sørensen wide-ranging powers

ft.com9 mesi fa

Danish group’s challenges mount despite winning reprieve after Hims & Hers withdraws plan to sell copycat Wegovy pill

ft.com6 mesi fa

Acquisitions fuel pharma group’s evolution as it prepares to lose patent protection on cancer drug Keytruda

ft.com4 mesi fa

Investors have started to reward turnaround effort under Slawomir Krupa

ft.com6 mesi fa

San Diego company’s lead drug is a potential alternative to vaccines for vulnerable patients

ft.com9 mesi fa

Reshuffle in preparation for 2028 US patent expiry of blockbuster cancer treatment Keytruda

ft.com5 mesi fa